
Slide Shows
about 6 hours ago
What do patients want from physicians in 2026?Latest News

Where one insurer dominates: 10 states with the least insurer competition

MGMA taps physician Chris DeRienzo to be leading voice for medical practices

What do patients want from physicians in 2026?

Should your practice buy new, refurbished or leased medical equipment? How to compare total cost

RFK Jr.'s reshaped USPSTF set to resume work on screening recommendations
Shorts










Medical Device and Technology
Latest Videos
Medical Economics Digital Edition










All News

The top news stories in medicine today.

7 numbers physicians should know before buying, plus 4 questions to ask

New AMA data show limited insurer competition in commercial and Medicare Advantage markets, which can cut into physicians’ negotiating power and payment.

We know artificial intelligence is already helping physicians treat patients. Why wait because of speculation about what might happen?

With projected shortfalls of 86,000 to more than 187,000 physicians within a decade, burnout, an aging workforce and capped residency slots are squeezing supply. Here are the training, payment, prior authorization and workplace changes that could help close the gap.

Wrong drugs, misread scans led to more California disciplinary cases than fraud or DUIs, study finds
The board's own researchers found a gap in first-attempt exam pass rates between physicians disciplined for what they didn't know and those disciplined for other reasons.


The decision leaves the FDA under acting leadership as Senate Republicans race to confirm nominees before Democrats take control in January.

Starting Jan. 1, Medicare will pay 20% less for the lower-valued service when an office visit billed with modifier 25 falls on the same day as a zero-day global procedure. One claims report priced at local 2027 rates shows independent practices their exposure, and three documentation habits protect the visits that still qualify for full payment.

The Commerce Department’s Section 232 investigation could bring new tariffs on imported medical devices and supplies. Targeted reserves, procurement preferences and a faster FDA pathway for switching to U.S. suppliers would do more to bring device manufacturing home.





























